Whan In Pharm Co.,Ltd. (KRX:016580)
South Korea · Delayed Price · Currency is KRW 9,840.00
-160.00 (-1.60%)
Aug 21, 2026, 3:30 PM KST
Whan In Pharm Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 273,474 | 255,214 | 259,596 | 230,394 | 198,935 | 177,776 |
Revenue Growth | 5.71% | -1.69% | 12.68% | 15.81% | 11.90% | 3.54% |
Gross Profit Gross Profit Growth | 98,959 | 86,404 | 93,665 | 98,943 | 98,658 | 93,359 |
Operating Income Operating Income Growth | 22,313 | 13,019 | 21,495 | 30,170 | 29,810 | 31,276 |
Net Income Net Income Growth | 20,452 | 13,595 | 23,381 | 29,774 | 23,921 | 26,660 |
Earnings Per Share EPS Growth | 1170.89 | 857.41 | 1531.45 | 1950.23 | 1566.86 | 1746.00 |
EPS Growth | 8.98% | -44.01% | -21.47% | 24.47% | -10.26% | 13.98% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 66,642 | 63,720 | 52,581 | 78,457 | 87,292 | 145,962 |
Total Debt Total Debt Growth | 567.99 | 679 | 413.74 | 632.03 | 249.94 | 1,721 |
Net Cash (Debt) Net Cash Growth | 66,074 | 63,041 | 52,167 | 77,825 | 87,042 | 144,241 |
Net Cash Growth | 46.59% | 20.84% | -32.97% | -10.59% | -39.66% | 25.68% |
Net Cash Per Share Net Cash Per Share Growth | 3782.74 | 3975.80 | 3416.99 | 5097.57 | 5701.29 | 9447.84 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 17,666 | 9,044 | 20,693 | 23,197 | 16,851 | 35,318 |
Capital Expenditures CapEx Growth | -2,604 | -2,850 | -27,357 | -30,531 | -33,650 | -4,387 |
Free Cash Flow Free Cash Flow Growth | 15,062 | 6,194 | -6,664 | -7,334 | -16,799 | 30,931 |
Free Cash Flow Growth | 79.42% | - | - | - | - | 109.47% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 36.19% | 33.86% | 36.08% | 42.95% | 49.59% | 52.52% |
Operating Margin | 8.16% | 5.10% | 8.28% | 13.10% | 14.99% | 17.59% |
Pretax Margin | 9.34% | 5.85% | 10.38% | 14.67% | 14.98% | 19.06% |
Profit Margin | 7.48% | 5.33% | 9.01% | 12.92% | 12.03% | 15.00% |
FCF Margin | 5.51% | 2.43% | -2.57% | -3.18% | -8.44% | 17.40% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 300.000 | 300.000 | 300.000 | 300.000 | 300.000 | 300.000 |
Dividend Per Share Growth | 0% | 0% | 0% | 0% | 0% | 0% |
Dividend Yield | 2.99% | 2.65% | 2.61% | 2.10% | 1.83% | 1.84% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.40 | 12.71 | 7.71 | 7.71 | 11.23 | 10.19 |
Forward PE | 8.30 | 12.26 | 8.95 | 10.19 | 11.78 | 10.83 |
P/FCF Ratio | 12.08 | 27.90 | - | - | - | 8.79 |
PS Ratio | 0.67 | 0.68 | 0.70 | 1.00 | 1.35 | 1.53 |